Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
07:10:13 EDT Sun 19 May 2024
Enter Symbol
or Name
USA
CA



Q:DCTH - DELCATH SYSTEMS INC - http://www.delcath.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
DCTH - Q0.16.95·7.770.17.57+0.618.8334.22,3752,0577.05  7.71  7.007.99  2.2519:59:55May 1415 min RT 2¢

Recent Trades - Last 10 of 2057
Time ETExPriceChangeVolume
19:59:55Q7.570.61500
19:58:42Q7.560.60500
18:55:33Q7.660.70300
18:53:33Q7.700.74100
18:53:18Q7.700.74600
18:37:30Q7.56060.60062
17:32:26Q7.640.68100
17:31:29Q7.560.601
16:24:41Q7.520.56900
16:23:24Q7.520.56100

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2024-05-14 07:30U:DCTHNews ReleaseDelcath Systems Reports First Quarter 2024 Results and Business Highlights
2024-05-07 08:30U:DCTHNews ReleaseDelcath Systems to Host First Quarter 2024 Earnings Call
2024-05-06 09:00U:DCTHNews ReleasePublication of Results from Pivotal FOCUS Study in Metastatic Uveal Melanoma Patients treated with HEPZATO KIT
2024-05-03 17:15U:DCTHNews ReleaseDelcath Systems Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2024-04-04 08:35U:DCTHNews ReleaseDelcath Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
2024-03-26 07:30U:DCTHNews ReleaseDelcath Systems Reports Fourth Quarter and Full Year 2023 Results and Provides Business Update
2024-03-20 08:15U:DCTHNews ReleaseDelcath Systems Closes $7 Million Private Placement
2024-03-19 09:00U:DCTHNews ReleaseDelcath Systems to Host Fourth Quarter and Full Year 2023 Results and Business Update Call
2024-03-18 17:20U:DCTHNews ReleaseDelcath Systems Appoints Martha S. Rook as Chief Operating Officer
2024-03-15 08:20U:DCTHNews ReleaseDelcath Systems Announces $7 Million Private Placement
2024-03-08 17:00U:DCTHNews ReleaseDelcath Systems Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2024-03-08 09:00U:DCTHNews ReleaseDelcath Systems to Participate in Upcoming Investor Conferences
2024-02-22 17:00U:DCTHNews ReleaseDelcath Systems Announces Healthcare Setting Locator for HEPZATO(TM) KIT (melphalan/Hepatic Delivery System)
2024-02-16 17:00U:DCTHNews ReleaseDelcath Systems Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2024-01-31 08:00U:DCTHNews ReleaseDelcath Systems Receives Permanent J-Code (J9248) for HEPZATO ¢ „ ¢ (melphalan/Hepatic Delivery System) Effective April 1, 2024
2024-01-23 08:00U:DCTHNews ReleaseDelcath Systems to Participate in a Fireside Chat at the Lytham Partners 2024 Investor Select Conference
2024-01-16 08:00U:DCTHNews ReleaseDelcath Systems Announces U.S. Launch and First Commercial Treatment Utilizing HEPZATO KIT ¢ „ ¢
2024-01-12 17:00U:DCTHNews ReleaseDelcath Systems Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2023-12-07 09:00U:DCTHNews ReleaseDelcath Systems Announces Publication by Independent Investigators of a Retrospective Analysis of Quality of Life in the Journal Melanoma Research
2023-11-15 17:00U:DCTHNews ReleaseDelcath Systems Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)